Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:38:31 PM
From: Proud Deplorable	Respond to of 1574439

India expands use of controversial drug for coronavirus despite safety concerns Top medical agency says its studies show hydroxychloroquine can prevent infection, but regulators in other countries are investigating adverse effects. There you go now STFU

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:42:58 PM
From: Proud Deplorable	1 Recommendation Recommended By locogringo Read Replies (1) \| Respond to of 1574439

OK YOU DAMN FOOL. GET LOST Treatments & Efficacy The three most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options (37% of COVID-19 treaters) 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S. and 13% in the U.K. The two most common treatment regimens for Hydroxychloroquine were: (38%) 400mg twice daily on day one; 400 mg daily for five days (26%) 400mg twice daily on day one; 200mg twice daily for four days Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:45:59 PM
From: Proud Deplorable	1 Recommendation Recommended By locogringo Respond to of 1574439

More Evidence Presented for Why Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons (AAPS)

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:48:07 PM
From: Proud Deplorable	Respond to of 1574439

The authorisation in Poland Poland is the only country to have actually authorised a chloroquine-containing product for supportive treatment of COVID-19.

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:49:46 PM
From: Proud Deplorable	Respond to of 1574439

Cuba: Early hydroxychloroquine potent against COVID-19 Cuba uses hydroxychloroquine and some other unique drugs in treatment of coronavirus, say Cuban medical authorities Vakkas Dogantekin \| 10.07.2020

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:51:34 PM
From: Proud Deplorable	Respond to of 1574439

Countries using hydroxychloroquine have low coronavirus fatality rate compared to countries that don’t, Association of American Physicians and Surgeons says We wrote about AAPS back in April after the group published a report of its study that showed hydroxychloroquine to have about 90 percent chance of helping COVID-19 patients. At the time, the group reported that a total number of 2,333 coronavirus patients were treated with HCQ, with or without zinc and the widely used antibiotic azithromycin. The report was based on observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill.

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:52:21 PM
From: Proud Deplorable	Respond to of 1574439

Turkey claims success treating COVID-19 with broad use of drug touted by Trump

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:53:03 PM
From: Proud Deplorable	Respond to of 1574439

Amid global controversy, Greece moves forward with chloroquine Seemingly unaffected by the controversy in the global scientific community, Greece has resumed production of chloroquine to treat cases of coronavirus and is conducting clinical trials with a "calm and distant approach", scientists there say.

To: J_F_Shepard who wrote (1256653)	8/24/2020 8:54:44 PM
From: Proud Deplorable	Respond to of 1574439

Bahrain among first countries to use Hydroxychloroquine to treat coronavirus